Asymptomatic episodes of device-registered atrial tachyarrhythmia are not associated with worse cardiac resynchronization therapy response

Europace

Volumn 16, Issue 8, 2014, Pages 1197-1204

  Verbrugge, Frederik Hendrik ^a,b   Nijst, Petra ^a,b   Van Herendael, Hugo ^a   De Vusser, Philip ^a   Jacobs, Linda ^a   Vercammen, Jan ^a   Verhaert, David ^a   Vandervoort, Pieter ^a,b   Dupont, Matthias ^a   Mullens, Wilfried ^a,b   Rivero Ayerza, Maximo ^a  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

Atrial fibrillation; Epidemiology; Outcome

Indexed keywords

AGED; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOEMBOLIC STROKE; CARDIOVASCULAR MORTALITY; CARDIOVERSION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TACHYCARDIA; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ADVERSE EFFECTS; ATRIAL FIBRILLATION; BELGIUM; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART RATE; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; TACHYCARDIA, SUPRAVENTRICULAR; TIME; TREATMENT OUTCOME;

ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; BELGIUM; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART RATE; HUMANS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, SUPRAVENTRICULAR; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905657508     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut434     Document Type: Article

References (17)

1. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003;91:2D-8D.
2. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-41.
3. Healey JS, Connolly SJ, Gold MR, IsraelCW, Van Gelder IC, Capucci A et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-9.
4. Boriani G, Gasparini M, Landolina M, Lunati M, Proclemer A, Lonardi G et al. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail 2011;13:868-76.
5. D'Ascia SL, D'Ascia C, Marino V, Lombardi A, Santulli R, Chiariello M et al. Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in nonischaemic dilated cardiomyopathy. Int J Clin Pract 2011;65:1149-55.
6. MullensW,Grimm RA, VergaT, DresingT, Starling RC, Wilkoff BL et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol 2009;53:765-73.
7. MullensW, Kepa J, De Vusser P, Vercammen J, Rivero-Ayerza M,Wagner P et al. Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy. Am J Cardiol 2011;108:409-15.
8. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
9. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999;83:897-902.
10. Rouleau F, Merheb M, Geffroy S, Berthelot J, Chaleil D, Dupuis JMet al. Echocardiographic assessment of the interventricular delay of activation and correlation to the QRS width in dilated cardiomyopathy. Pacing Clin Electrophysiol 2001;24:1500-6.
11. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-A study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357-66.
12. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995;26:135-6.
13. Caldwell JC, Contractor H, Petkar S, Ali R, Clarke B, Garratt CJ et al. Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace 2009;11:1295-300.
14. Borleffs CJ, Ypenburg C, van Bommel RJ, Delgado V, van Erven L, Schalij MJ et al. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy. Heart Rhythm 2009;6:305-10.
15. Santini M, Gasparini M, Landolina M, Lunati M, Proclemer A, Padeletti L et al. Devicedetected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol 2011;57:167-72.
16. Shanmugam N, Boerdlein A, Proff J, Ong P, Valencia O, Maier SK et al. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace 2012;14: 230-7.
17. Wilton SB, Leung AA, GhaliWA, Faris P, ExnerDV. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 2011;8:1088-94.